Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $94
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson maintains a Buy rating on Merit Medical Systems (NASDAQ:MMSI) and raises the price target from $93 to $94.
August 02, 2024 | 9:43 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst Mike Matson maintains a Buy rating on Merit Medical Systems and raises the price target from $93 to $94.
The analyst's maintained Buy rating and slight increase in the price target from $93 to $94 indicate positive sentiment and confidence in the company's performance, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100